Motilal Oswal predicts potential turnaround for Colgate-Palmolive (India) stock, upgrades to ‘Buy’ with target price of Rs 2,850, citing tax relief, improving demand trends, and focus on premium products. Despite weak Q2 results, margins remain strong. GST rate cut on oral care products expected to boost recovery. Colgate shifts focus to innovation, rural growth, and expanding beyond oral care.